SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against IRadimed Corporation and Its Board of Directors and a Lead Plaintiff Deadline of November 10, 2014 -- IRMD
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 09/22/14 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of investors who purchased IRadimed Corporation ("IRadimed" or the "Company") (NASDAQ: IRMD) securities between July 15, 2014 and September 2, 2014.
For more information, click here:
The complaint alleges that throughout the Class Period IRadimed failed to disclose that: (a) the Company's infusion pump systems had been significantly modified, a fact that could significantly affect the safety and/or effectiveness of the devices; (b) as a result of said modifications, the Company's products are "adulterated" and "misbranded" under applicable federal regulations; (c) the Company's mRidium 3860+ infusion pump requires separate FDA clearance from its mRidium 3860 and mRidium 3850.
On September 3, 2014, IRadimed announced it had received a warning letter from the FDA requesting the Company cease all activities that misbrand or adulterate its mRidium 3860, mRidium 3850, and mRidium 3860+ infusion pumps.
If you suffered a loss in IRadimed you have until November 10, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit .
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.09.2014 - 23:59 Uhr
Sprache: Deutsch
News-ID 338118
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 285 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against IRadimed Corporation and Its Board of Directors and a Lead Plaintiff Deadline of November 10, 2014 -- IRMD"
steht unter der journalistisch-redaktionellen Verantwortung von
Levi & Korsinsky, LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
